Evonik has signed an agreement to acquire the LACTEL business of biodegradable polymers from DURECT Corporation for US$15 million. The transaction is expected to close by Q1 2021 pending the satisfaction of certain customary closing conditions.
An offer will be extended to each of the 15 employees of DURECT located in Birmingham, Alabama, which are associated with the LACTEL business to transition to Evonik.
“The acquisition of the Lactel business will strengthen both our innovation growth field Healthcare Solutions and Evonik’s position as a globally leading CDMO for drug delivery solutions”, said Johann-Caspar Gammelin, Head of the Nutrition & Care Division of Evonik.
LACTEL brand of biodegradable, PLGA-based polymers to be integrated into Evonik’s Health Care business.
The acquisition of the LACTEL business marks a consequential step in the growth agenda of the life-science division Nutrition & Care. The LACTEL business will benefit from fast-growing markets such as advanced drug delivery, biomaterials for tissue engineering, and the 3D printing of implantable medical devices.
“It has been a pleasure working with the highly motivated and talented LACTEL team. We have confidence that Evonik will apply its resources and commitment to excellence to enable the LACTEL product line and supporting team members to thrive,” noted James E. Brown, President and Chief Executive Officer of DURECT Corporation.
With Evonik’s global reach, existing and new customers will benefit from tapping into Health Care’s twelve global laboratories staffed with formulation, application and regulatory experts to assist in bringing their products faster to the market.
“The integration of the LACTEL business into Evonik’s market-leading portfolio of functional excipients, biomaterials and integrated CDMO services will strengthen our position as a preferred development partner and solutions provider for pharmaceutical and medical device customers,” added Thomas Riermeier, Head of the Health Care business line of Evonik.
0
Leave A Comment
SubmitAll Comments
Evonik and VESTARO consortium partners develop new generation of electric vehicle battery packs, the "Pure Performance Battery".
2022-03-17
The 4th Edition CPRJ Medical Plastics and Rubber Conference & Showcase kicked off today in Shanghai, China, discussing the new opportunities...
2021-11-04
Evonik's new VESTAMID polyamide 12 compound offers high fire protection for busbars.
2021-09-17
Evonik and UnionTech has agreed to set up a joint R&D laboratory for 3D printing technology in Shanghai, China.
2021-08-19
Evonik has acquired a minority stake in Chinese company UnionTech through its Venture Capital unit. The Shanghai-based company is active in ...
2020-12-15
The 3rd Edition CPRJ Medical Plastics and Rubber Conference & Showcase, with the theme of "Safe, Precise and Smart Manufacturing",...
2020-11-12
1
CHINAPLAS, Asia’s No. 1 plastics and rubber trade fair, will be s...
2
The countdown to the CHINAPLAS x CPRJ Recycling Conference and the...
3
With the guiding themes of climate protection, circular economy an...
4
After six years and a forced absence during the pandemic, interpac...
5
In view of the pandemic control measures in Shanghai and other pro...
1
Coveris has teamed up with UPM Raflatac to deliver new label and r...
2
Henkel launches Loctite 3296 for assembly of high performance ADAS...
3
Machine Solutions has acquired Vela, which designs and manufacture...
4
Davis-Standard’s HPE extruder and new DS-XEL control will drive r...
5
Teijin and Fujitsu agree to jointly develop blockchain-based comme...